References

Article References for Physicians

  1. Weintraub WS, et al. Frequency of repeat coronary bypass or coronary angioplasty after coronary artery bypass surgery using saphenous venous grafts. Americal Journal of Cardiology. 1994;73:103-12.
  2. Hughes GC, et al. Neovascularization after transmyocardial revascularization in a model of chronic ischemia. Annals of Thoracic Surgery. 1998;66:2029–36.
  3. Allen KB, et al. Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina. New England Journal of Medicine. 1999;341(14):1029-36.
  4. Burkhoff D, et al. Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomised trial. Lancet. 1999;354:885-90.
  5. Frazier OH, et al. Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease. New England Journal of Medicine. 1999;341(14):1021-8.
  6. Graham MM, et al. Angiographic quantification of diffuse coronary artery disease: reliability and prognostic value for bypass operations. Journal of Thoracic and Cardiovascular Surgery. 1999;118:618–27.
  7. Horvath K, et al. Up-regulation of vascular endothelial growth factor mRNA and angiogenesis after transmyocardial laser revascularization. Annals of Thoracic Surgery. 1999;68(3):825–9.
  8. Mukherjee D, et al. Direct myocardial revascularization and angiogenesis—How many patients might be eligible? American Journal of Cardiology. 1999;84:598-600.
  9. Sayeed-Shah U, et al. Combination TMR and gene therapy. Semin Thorac Cardiovasc Surg. 1999;11(1):36–9.
  10. Schofield PM, et al. Transmyocardial laser revascularization in patients with refractory angina: a randomized controlled trial. Lancet. 1999;353(9152):519–24.
  11. Thourani VH, et al. Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting.  Annals of Thoracic Surgery. 1999;67: 1045-52.
  12. Aaberge L, et al. Transmyocardial revascularization with CO2 laser in patients with refractory angina pectoris: clinical results from the Norwegian randomized trial. Journal of the American College of Cardiology. 2000;35:1170–7.
  13. Allen KB, et al. Transmyocardial laser revascularization combined with coronary artery bypass grafting: A multicenter, blinded, prospective, randomized, controlled trial. Journal of Thoracic and Cardiovascular Surgery. 2000;119:540-9.
  14. Flacone C, et al. Silent myocardial ischemia in diabetic  and nondiabetic patients with coronary artery disease. International Journal of Cardiology. 2000;90: 219-227.
  15. Hughes GC, et al. Induction of angiogenesis after TMR: a comparison of holmium: YAG, CO2, and excimer lasers. Annals of Thoracic Surgery. 2000;70:504–9.
  16. Yamamoto N, et al. Histologic evidence that basic fibroblast growth factor enhances the angiogenic effects of transmyocardial laser revascularization. Basic Research in Cardiology. 2000;95(1):55–63.
  17. Osswald B, et al. Does the completeness of revascularization affect early survival after coronary artery bypass grafting in elderly patients? European Journal of Cardiothoracic Surgery. 2001;20:120–6.
  18. Prendergast BC, et al. Influence of the availability of laser transmyocardial revascularization on surgical strategy in patients with advance coronary artery disease. Cardiology. 2001;95(2):90-5.
  19. Aaberge L, et al. Continued symptomatic improvement three to five years after transmyocardial revascularization with CO(2) laser: a late clinical follow-up of the Norwegian randomized trial with transmyocardial revascularization. Journal of the American College of Cardiology. 2002;39(10):1588–93.
  20. Hughes GC, et al. Revascularization versus denervation: what are the mechanisms of symptom relief? In: Abela G, editor. Myocardial revascularization: novel percutaneous approaches. New York: Wiley-Liss; 2002. p. 63–79.
  21. Hughes GC, et al. A comparison of mechanical and laser transmyocardial revascularization for induction of angiogenesis and arteriogenesis in chronically ischemic myocardium. Journal of the American College of Cardiology. 2002;39(7):1220–8.
  22. Lutter G, et al. The combined use of transmyocardial laser revascularization (TMLR) and fibroblastic growth factor (FGF-2) enhances perfusion and regional contractility in chronically ischemic porcine hearts. European Journal of Cardiothoracic Surgery. 2002;22:753-61.
  23. Myers J, et al. Do transmyocardial and percutaneous laser revascularization induce silent ischemia? An assessment by exercise testing. American Heart Journal. 2002;143(6):1052-7.
  24. Gibbons RJ, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Chronic Stable Angina). Circulation. 2003;107(1):149-58.
  25. Heilmann CAU, et al. Transmyocardial laser revascularization combined with vascular endothelial growth factor121 (VEGF121) gene therapy for chronic myocardial ischemia – do the effects really add up? European Journal of Cardiothoracic Surgery. 2003;23:74-80.
  26. Peterson ED, et al. From controlled trials to clinical practice: monitoring transmyocardial revascularization use and outcomes. Journal of the American College of Cardiology. 2003;42:1611–6.
  27. Allen KB, et al. Adjunctive transmyocardial revascularization: Five-year follow-up of a prospective, randomized trial. Annals of Thoracic Surgery. 2004;78:458-65.
  28. Allen KB, et al. Transmyocardial revascularization: 5-year follow-up of a prospective, randomized multicenter trial. Annals of Thoracic Surgery. 2004;77:1228-34.
  29. Bridges CR, et al. The Society of Thoracic Surgeons practice guideline series: transmyocardial laser revascularization. Annals of Thoracic Surgery. 2004;77:1494-502.
  30. Eagle KA, et al. ACC/AHA 2004 Guideline Update for Coronary Artery Bypass Graft Surgery. Circulation. 2004;110:e340-7.
  31. Frazier OH, et al. Transmyocardial laser revascularization as an adjunct to coronary artery bypass grafting: a randomized, multicenter study with 4-year follow-up. Texas Heart Institute Journal. 2004;31:231–9.
  32. Hughes GC, et al. Regional cardiac sympathetic innervation early and late after transmyocardial laser revascularization. Journal of Cardiac Surgery. 2004;19:21-27.
  33. Huikeshoven M, et al. The vascular response induced by transmyocardial laser revascularization is determined by the size of the channel scar: results of CO2, holmium and excimer lasers. Lasers in Surgery and Medicine. 2004;35:35–40.
  34. Klein HM, et al. Autologous bone marrow-derived stem cell therapy in combination with TMLR. A novel therapeutic option for patients with end-stage coronary heart disease: report on 2 cases. Heart Surgery Forum. 2004;7(5):E416–9.
  35. Mouli SK, et al. What is the optimal channel density for transmyocardial laser revascularization? Annals of Thoracic Surgery. 2004;78:1326-31.
  36. van der Sloot JA, et al. Transmyocardial revascularization using an XeCl excimer laser: results of a randomized trial. Annals of Thoracic Surgery. 2004;78: 875–82.
  37. DeVon H, et al. Symptoms of unstable angina in patients with and without diabetes. Research in Nursing and Health. 2005;28: 136-43.
  38. Di Mauro M, et al. Reoperative coronary artery bypass grafting: Analysis of early and late outcomes. Annals of Thoracic Surgery. 2005;79:81-7.
  39. Gowdak LH, et al. Cell therapy plus transmyocardial laser revascularization for refractory angina. Annals of Thoracic Surgery. 2005;80(2):712–4.
  40. Horvath KA, et al. Improvement of myocardial contractility in a porcine model of chronic ischemia using a combined transmyocardial revascularization and gene therapy approach. J Thoracic and Cardiovascular Surgeon. 2005;129:1071-7.
  41. Kleisi T, et al. In the current era, complete revascularization improves survival after coronary artery bypass surgery. Journal of Thoracic and Cardiovascular Surgery. 2005;129(6):1283–91.
  42. Patel AN, et al. Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: A prospective randomized study. Journal of Thoracic and Cardiovascular Surgery. 2005;130:1631-8.
  43. Cheng D, et al. Transmyocardial laser revascularization: A meta-analysis and systematic review of controlled trials. Innovations. 2006;1:295-313.
  44. Diegeler A, et al. Transmyocardial laser revascularization: A consensus statement of the International Society of Minimally Invasive Cardiothoracic Surgery (ISMICS) 2006. Innovations. 2006;1:314-322.
  45. Losordo DW, et al. Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: A phase I/lIa double-blind, randomized controlled trial. Circulation. 2007;115:3165 -72.
  46. Patel AN, et al. Improved cell survival in infracted myocardium using a novel combination transmyocardial laser and cell delivery system. Cell Transplantation. 2007;16;899-905.
  47. Tran R., et al.  Transmyocardial Laser Revascularization Enhances Blood Flow within Bypass Grafts.  Innovations. 2007;2: 226–230.
  48. Allen KB, et al. Transmyocardial laser revascularization: From randomized trials to clinical practice. A review of techniques, evidence-based outcomes, and future directions. Anesthesiology Clinics. 2008;26:501-19.
  49. Atluri P, et al. Transmyocardial revascularization to enhance vasculogenesis and hemodynamic function. Journal of Thoracic and Cardiovascular Surgery. 2008:135:283-91.
  50. Reyes G, et al. Bone marrow laser revascularisation for treating refractory angina due to diffuse coronary heart disease. European Journal of Cardiothoracic Surgery. 2009;36:192-4.
  51. Wehberg KE, et al. Intramyocardial injection of autologous platelet-rich plasma combined with transmyocardial revascularization. Cell Transplantation. 2009;18:353-9.
  52. Lloyd-Jones D. et al.  AHA Heart Disease and Stroke Statistics – 2010 Update.  Circulation. 2010;121:e46-e215.
  53. Williams B, et al.  Patients with Coronary Artery Disease Not Amenable to Traditional Revascularization: Prevalence and 3-Year Mortality. Catheterization and Cardiovascular Interventions. 2010; 75:886–891.
  54. Reyes G, et al. Mid term results after bone marrow laser revascularization for treating refractory angina. BMC Cardiovascular Disorders. 2010;10:42.
  55. VL Roger, et al.  Heart Disease and Stroke Statistics_2011 Update: A Report From the American Heart Association Circulation. 2011;123;e18-e209

 Back to Top ^